1998
DOI: 10.1016/s0958-6946(99)00024-2
|View full text |Cite
|
Sign up to set email alerts
|

Selection and Characterisation of Lactobacillus and Bifidobacterium Strains for Use as Probiotics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
199
1
12

Year Published

2000
2000
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 324 publications
(217 citation statements)
references
References 9 publications
4
199
1
12
Order By: Relevance
“…Moreover, L. rhamnosus VT1 was able to survive the effect of pH = 3 for 180 min in 84%. This is comparable with the known commercial strains L. acidophilus LA-1 or L. rhamnosus GG found by Prasad et al (1998). Their survival was 94% and 83% at pH = 3 during 180 min, respectively.…”
Section: Mutual Behaviour Of Lab and Spoilage Organismssupporting
confidence: 87%
“…Moreover, L. rhamnosus VT1 was able to survive the effect of pH = 3 for 180 min in 84%. This is comparable with the known commercial strains L. acidophilus LA-1 or L. rhamnosus GG found by Prasad et al (1998). Their survival was 94% and 83% at pH = 3 during 180 min, respectively.…”
Section: Mutual Behaviour Of Lab and Spoilage Organismssupporting
confidence: 87%
“…The main characteristics of these probiotic strains are acid and bile salt resistance (Prasad et al, 1998). Most lactobacilli already have a beneficial effect in the small intestine, whereas the largest numbers of bifidobacteria are often found in the colon.…”
Section: Introductionmentioning
confidence: 99%
“…However, studies conducted to date have generally indicated a positive effect on one particular cellular function, such as phagocytosis or cytokine-secreting activity (Schiffrin et al, 1995;Kishi et al, 1996;Donnet-Hughes et al, 1999). Our laboratory has recently identi®ed and characterised a new strain of Bi®dobacterium lactis (B. lactis HN019) which has potent enhancing properties on several aspects of cellular immunity in animal models (Gill, 1998;Prasad et al, 1999). Mice fed B. lactis HN019 show enhanced phagocytosis and tumour killing activity, enhanced lymphocyte proliferation and increased cytokine-secreting capacity (Gill, 1998;Gill et al, 2000).…”
Section: Introductionmentioning
confidence: 99%